baber/WOPTO huggingface dataset:
Patent MX-PA03011102-A (MX)
Title: Pharmaceutical formulation consisting of a plant dry extract with a calcium coating.
Inventor: MICHAEL A POPP
IPC: A61P3/14
Filed: 2002-04-10
Abstract: The invention relates to a pharmaceutical formulation consisting of a calcium salt and of a plant dry extract and provided in the form of a coated tablet, whereby the formulation has a core comprised of at least one plant dry extract that is enclosed by at least one coating made of at least one calcium salt. The plant extracts used for the core can be selected among: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard flower); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (red clover); Oenothera biennis hom. (evening primrose); Glycine soja (soybean); Serenoa repens (saw palmetto); Urtica dioica (stinging nettle), particularly the roots thereof; Cucurbita pepo (pumpkin), particularly the seeds thereof; Pygeum africanum; as well as suitable mixtures thereof.
Patent MX-PA04002549-A (MX)
Title: Device for application of labels to containers.
Inventor: HANS-ULRICH GOLLER
IPC: B65C9/06
Filed: 2002-09-19
Abstract: The device serves to apply labels to containers (10), for example, drinks bottles. The orientation of the container (10) is determined by means of an electro-optical device (18) and corresponding signals are generated. Said signals control a device (24, 32) for turning the container to a set orientation, such that labels can be applied in a pre-determined position on the container (10).
Patent MX-PA04003504-A (MX)
Title: Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone.
Inventor: DARKO MIKUS
IPC: C07K7/04
Filed: 2001-11-29
Abstract: Computational analysis was used to define repetitive and bioactive regions of the pro-opiomelanocortin SYSMEHFRWGKPV and YGGFM. Cytoprotection model of the ethanol induced gastric lesion was used to prove the additive cytoprotective effects of the combination of sequences SYSMEHFRWGKPV and YGGFM, when compared to the individual peptid sequences. The combination of two sequences SYSMEHFRWGKPV and YGGFM is denoted KOMET and patented. The purpose of the administration of KOMET is to obtain better and stronger pharmacologic effects on the systemic and local modulation of the inflammation and wound healing. Additional structural formulas which represent different combinations of both sequences were also defined as: KOMET-1 with sequence YGGFMSYSMEHFRWGKPVYGGFM, KOMET-2 with sequence YGGFMSYSMEHFRWGKPV and KOMET-3 with sequence SYSMEHFRWGKPVYGGFM.
Patent MX-PA04004097-A (MX)
Title: Method and appparatus for detecting holes in plastic containers.
Inventor: DONALD WAYNE MILLER
IPC: G01N29/04
Filed: 2002-10-31
Abstract: A method and an apparatus for monitoring the production of blow molded plastic containers (20) includes a columnator (26) and sound detector (24) responsive to a defect sound of pressure fluid escaping from a container being formed in a mold cavity (14). The columnator is effective to filter the defect sound from ambient noise. An output signal generated by the sound detector is processed to generate a control signal used to reject a defective container. Preferably, the open end of the columnator is positioned between 20 degree and 150 degree from the preform loading station in a rotary platform (12) blow molding machine.
Patent MX-PA04006330-A (MX)
Title: System and method for residential emissions trading.
Inventor: BARTELS CARLTON
IPC: G06Q30/00
Filed: 2002-12-19
Abstract: The present invention is directed to a method of residential emissions trading and a residential emissions trading commodity. In particular, an embodiment of the present invention is a method for identifying, quantifying, and aggregating reductions in residential emissions into a tradable commodity. The step of quantifying the emissions reduction may further comprise the steps of measuring an energy savings resulting from the energy savings opportunity and calculating the emissions reduction resulting from the energy savings. The method may further comprise the steps of verifying the quantification of the emissions reduction and monitoring the residential energy savings opportunities and the quantification of the emissions reduction.
Patent MX-PA04008411-A (MX)
Title: Compressor.
Inventor: TSUKAMOTO HIDEAKI
IPC: F04C18/00
Filed: 2004-08-30
Abstract: Described is a compressor which avoids oscillation and noise caused by a suction silencer. The compressor costs can be reduced by increasing the centrifugal force generated by the rotation of a rotary axis, thus avoiding the use of an oil extraction means such as a hydraulic wheel. The invention comprises a compression mechanical unit elastically supported by a spring which prevents the unit from being damaged by colliding against the inner surface of a sealed container, and from a heavy impact during transportation. The suction silencer opposite the compression mechanical unit 8 comprises both protruding portions that are brought into contact (10) with the compression mechanical unit 4 and protruding portions that are not brought into contact (9) therewith, said portions being arranged over the surface of the silencer. A rotary axis 25 comprises an oil-feeding orifice 32 arranged in such a manner that the central portion 40 of a lower oil feeding orifice 32A is displaced 1.66 mm alon g a central axis 50 of the rotary axis 25 while tilted about 1.2 degrees in the direction of the diversion with respect to the central axis 50. The compression mechanical unit 4 that is elastically supported by the spring 23 within the main body of a container is therefore downwardly pressed towards the spring 23 by a flat pressing portion 24B of a U-shaped retaining element 24.
Patent MX-PA04009031-A (MX)
Title: Primitive and proximal hepatic stem cells.
Inventor: BRUCE ANDREW T
IPC: C12N5/074
Filed: 2003-03-14
Abstract: Hepatic progenitors comprise two populations of human hepatic stem cells, primitive and proximal hepatic stem cells, and two populations of committed progenitors, one for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very small fraction of the liver cell population and give rise to proximal hepatic stem cells constituting a much larger fraction of the liver. Human proximal hepatic stem cells give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem cells are the primary stem cells for the human liver. Human primitive hepatic stem cells may be isolated by immunoselection from human livers or culturing human liver cells under conditions which select for a human primitive hepatic stem cell. Proximal hepatic stem cells may be isolated by immunoselection, or by culturing human liver cells under conditions which include a developmental factor. Proximal hepatic stem cells may also be isolated by culturing colonies comprising a primitive hepatic stem cell under conditions which include a developmental factor. Resulting compositions may be used for treating liver disorders and for producing bioartificial organs.
Patent MX-PA04010394-A (MX)
Title: Biodegradable saturated/unsaturated thermoplastic polyesters.
Inventor: MILIZIA TIZIANA
IPC: C08G63/78
Filed: 2003-04-22
Abstract: Biodegradable aliphatic thermoplastic copolyesters of the saturated-unsaturated type, utilizable for the production of several types of articles such as films, sheets, nets, expanded molded products, and the like, and process for their production.
Patent MX-PA04010687-A (MX)
Title: Trans-epicutaneous administration form for treating restless leg syndrome.
Inventor: ERWIN SCHOLLMAYER
IPC: A61K31/381
Filed: 2003-05-05
Abstract: The invention relates to a trans-epicutaneous pharmaceutical composition containing Rotigotin for effective treatment of Restless Leg Syndrome (RLS), especially in the form of a transdermal therapeutic system (TDS) based on acrylate or silicone having a surface of 2.5 - 20 cm2 and containing 1.125 9.0 mg/cm2 Rotigotin as an active component against Restless Leg Syndrome, which, according to the International Restless Leg Syndrome Study Group (IRLSSG) Rating Scale, results in an improvement in the conditions of human Restless Leg Syndrome patients in comparison with a placebo treatment of 2 units or more, after administration over a period of time of at least 8 days.
Patent MX-PA05001427-A (MX)
Title: Process for preparing 5-(4- fluorophenyl)-1 -[2-((2r, 4r)-4 -hydroxy -6-oxo- tetrahydro- pyran-2 -yl) ethyl]- 2-isopropyl -4-phenyl -1h-pyrrole -3 -carboxylic acid phenylamide.
Inventor: PAMMENT MICHAEL GERARD
IPC: C07B61/00
Filed: 2003-07-25
Abstract: A method for preparing 5- (4-fluorophenyl) -I-[2 -((2R, 4R) -4-hydroxy -6-oxo- tetrahydro -pyran-2 -yl)- ethyl]-2 -isopropyl -4-phenyl -1H-pyrrole -3 -carboxylic acid phenylamide (I), a key intermediate in the synthesis of atorvastatin calcium, is described.
Patent MX-PA05002734-A (MX)
Title: Acyl derivatives of 5- (2-(4 -(1, 2 benzisothiazole -3- yl)-1- piperazinyl) ethyl)- 6-chloro -1, 3-dihydro -2h -indol-2 -one having neuroleptic activity.
Inventor: COLON-CRUZ ROBERTO
IPC: C07D417/12
Filed: 2003-10-13
Abstract: A process for preparing acyl derivatives as prodrugs of 5- (2- (4- (1, 2 benzisothiazole- 3-yl)- 1-piperazinyl) ethyl-6 -chloro-1, 3-dihydro -2H- indol- 2- one and pharmaceutically acceptable acid addition salts and methods of use as an antipsychotic.
Patent MX-PA05004078-A (MX)
Title: Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists.
Inventor: DAVID MATTHEW WILSON
IPC: C07D211/46
Filed: 2003-10-14
Abstract: The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.
Patent MX-PA05006792-A (MX)
Title: Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents.
Inventor: MAZIASZ TIMOTHY
IPC: A61K31/421
Filed: 2003-12-19
Abstract: The present invention provides compositions and methods for the treatment of herpes virus infections. In one aspect, the invention provides a combination therapy for treating a herpes virus infection comprising the administration to a subject of an anti-herpes virus agent in combination with a cyclooxygenase-2 selective inhibitor. In another aspect, the invention provides a mono therapy for treating a herpes virus infection comprising administering a cyclooxygenase-2 selective inhibitor to a subject. Preferably, the cyclooxygenase-2 selective inhibitor is selected from the group consisting of celecoxib, deracoxib, valdecoxib, rofecoxib, lumiracoxib, etoricoxib, parecoxib, 2-(3, 4-difluoro-phenyl)-4 -(3-hydroxy-3 -methylbutoxy)-5 -`4- (methylsulphonyl) phenyl!-3(2H)- pyridazinone, and (S)-6, 8-dichloro-2- (trifluoromethyl) -2H-1-benzopyran-3 -carboxylic acid; and the anti-herpes virus agent selected from the group consisting of ganciclovir, foscarnet, cidofovir, acycloguanosine, tri-fluorothymidine, acyclovir, famciclovir, and valaciclovir.
Patent MX-PA05007857-A (MX)
Title: Indole-derivative modulators of steroid hormone nuclear receptors.
Inventor: MITCHELL IRVIN STEINBERG
IPC: C07D405/02
Filed: 2004-01-20
Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
Patent MX-PA05011369-A (MX)
Title: Method of preparing a cheese flan.
Inventor: SALMONES CANDIDO SALMON GARCIA
IPC: A23L9/10
Filed: 2004-04-27
Abstract: The invention relates to a method of preparing a cheese flan. The inventive method comprises the following steps: a mixture of milk, sugar, fresh cream cheese and liquid egg is prepared and flavoured with lemon peel and cinnamon; the mixture obtained and liquid caramel are dosed linearly into a vacuum-sealed container; the product is cooked by means of pasteurisation in the aforementioned container; and, finally, the product is cooled to a storage temperature of between 0O and 8O C.
Patent MX-PA05011490-A (MX)
Title: A process for the preparation of low branch content polybutadiene.
Inventor: VALENTI SILVIA
IPC: C08F36/06
Filed: 2005-10-25
Abstract: A process for the preparation of low branch content polybutadiene comprising: (a) a first butadiene polymerisation stage; (b) treatment of the polymer solution obtained upon completion of stage (a) with a coupling agent selected from: (i) polyunsaturated natural oils; (ii) butadiene and/or isoprene oligomers; (iii) butadiene and/or isoprene co-polymers with vinylarene monomers; the unsaturations present in compounds (i) - (iii) being at least partially substituted with groups selected from epoxides, anhydrides and esters; (c) recovery of the low branch content polybutadiene obtained upon completion of stage (b).
Patent MX-PA05012899-A (MX)
Title: 3-aminomethyl-pyrrolidines as n-type calcium channel blockers.
Inventor: DING YANBING
IPC: C07D417/02
Filed: 2004-05-28
Abstract: The invention relates to compounds that are derivatives of 3-aminomethyl-pyrrolidine of the formulas: wherein: Y is (X2)1A or (X1)mCR4A2; W is CR4 or N; R1-R4 are noninterfering substituents; n is 0-7; 1 and m are independently 0 or 1; X1-X2 are linkers; each A is independently a 5-7 membered optionally substitued aromatic or aliphatic ring optionally containing one or more heteroatoms selected from O, N and S. They generally contain at least one benzhydril moiety and are useful in treating conditions which benefit from blocking calcium ion channels.
Patent MX-PA06000820-A (MX)
Title: Expansion tank with double diaphragm.
Inventor: LOMBARI ROBERT
IPC: F24D3/00
Filed: 2004-07-19
Abstract: A double-diaphragm bladder. The bladder comprises a non-flexible diaphragm having a peripheral edge and a flexible diaphragm having a peripheral edge. The non- -flexible diaphragm has an aperture adapted and constructed to be connected to a liquid port, and the peripheral edges of the non-flexible diaphragm and the flexible diaphragm are sealed together. The bladder is suitable for use in an expansion tank.
Patent MX-PA06001645-A (MX)
Title: Isothiazoloquinolones and related compounds as anti-infective agents.
Inventor: LUCIEN EDLAINE
IPC: A61K31/435
Filed: 2004-08-04
Abstract: The invention provides compounds and salts of Formula (I) and Formula (II): which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula (I) and Formula (II). The variables A1, R2, R3, R5, R6, R7, A8 and R9 are defined herein. Certain compounds of Formula (I) and Formula (II) disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula (I) or Formula (II) and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula (I) or Formula (II) as the only active agent or may contain a combination of a compound of Formula (I) or Formula (II) and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
Patent MX-PA06002551-A (MX)
Title: Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists.
Inventor: NUKUI SEIJI
IPC: C07D401/12
Filed: 2004-08-23
Abstract: This invention provides a compound of the formula (I): wherein A represents a phenyl group or the like: B represents an aryl or the like: E represents a 1,4-phenylene group; R1 and R2 independently represent a hydrogen atom or the like: R3 and R4 independently represent a hydrogen atom or the like: R5 represents -CO2H or the like:R6 represents an alkyl group having from 1 to 6 carbon atoms or the like: X represents a methylene group or the like. These compounds are useful for the treatment of disease conditions mediated by prostaglandin such as pain, or the like in mammalian. The compounds act as antagonists of the prostaglandin E2 receptor. This invention also provides a pharmaceutical composition comprising the above compound.
Patent MX-PA06004590-A (MX)
Title: Stable compositions of spores, bacteria and/or fungi.
Inventor: SANDERS LISA M
IPC: C11D/
Filed: 2004-10-18
Abstract: The present invention relates to a stable cleaning composition including a borate salt and spores (bacterial or fungal), vegetative bacteria, or fungi. The composition can also include a polyol.
Patent MX-PA06008974-A (MX)
Title: Measuring fluid flow to a suckling baby.
Inventor: ROITMAN LIPA LEON
IPC: G01F1/36
Filed: 2005-02-08
Abstract: A system for measuring fluid intake by a sucking baby. The system includes: a feeding pathway for fluid flow from the fluid source to the baby's mouth, wherein the feeding pathway has a first opening in communication with the fluid source and a second opening in communication with the baby's mouth; and an indicator pathway for indicating the amount of fluid provided to the baby's mouth through the feeding pathway, wherein the indicator pathway has a first opening in communication with the fluid source and a second opening in communication with the baby's mouth. The amount of fluid drawn into the indicator pathway is indicative of the amount of fluid drawn into the feeding pathway.
Patent MX-PA06009074-A (MX)
Title: Vapor-compression evaporation system and method.
Inventor: HOLTZAPPLE MARK T
IPC: F28F3/04
Filed: 2005-02-10
Abstract: According to one embodiment of the invention, a vapor-compression evaporation system includes a plurality of vessels in series each containing a feed having a nonvolatile component. A first set of the plurality of vessels includes vapor- compression evaporators and a second set of the plurality of vessels includes multi-effect evaporators. A mechanical compressor is coupled to the last vessel in the series of vapor-compression evaporators and is operable to receive a vapor therefrom. A turbine is coupled to, and operable to drive, the mechanical compressor. A pump is operable to deliver a cooling liquid to the mechanical compressor, and a tank is coupled to the mechanical compressor and is operable to separate liquid and vapor received from the mechanical compressor. A plurality of heat exchangers is coupled inside respective ones of the vessels, wherein the heat exchanger in the first vessel in the first set is operable to receive the vapor from the tank, and at least some of the vapor condenses therein. The heat of condensation provides the heat of evaporation to the first vessel in the first set, and at least some of the vapor inside the first vessel in the first set is delivered to the heat exchanger in the next vessel in the first set, whereby the condensing, evaporating, and delivering steps continue until the last vessel in the second set is reached.
Patent MX-PA06010879-A (MX)
Title: Pyrazole compounds and uses related thereto.
Inventor: POWERS JAY P
IPC: C07D403/10
Filed: 2005-03-21
Abstract: Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
Patent MX-PA06011810-A (MX)
Title: Emulsion aggregation toner incorporating aluminized silica as a coagulating agent.
Inventor: PATEL RAJ D
IPC: G03G9/00
Filed: 2006-10-12
Abstract: The toner includes emulsion aggregation toner particles having a core and a shell. The core includes binder including a first non-crosslinked styrene acrylate polymer and a crosslinked styrene acrylate polymer, at least one colorant, at least one wax, and aluminized silica. The shell includes a second non-crosslinked styrene acrylate polymer that is preferably the same as the non-crosslinked styrene acrylate polymer of the core. The aluminized silica is advantageously used as a coagulant in the emulsion aggregation formation of the toner. A developer containing the toner and a method of forming an image using the toner are also described.
Patent MX-PA06011955-A (MX)
Title: Physiological event handling system, method, and device; monitoring device and program product.
Inventor: HEINONEN TOMI
IPC: A61B5/021
Filed: 2005-04-15
Abstract: A system for handling a physiological event includes a monitoring device adapted to detect, sense, measure, simulate, intervent, or control one or more physiological parameters. The monitoring device is further adapted to transmit a signal including information corresponding at least to an identification of the monitoring device. The system also includes an event handling device adapted to receive signals from the monitoring device, including information corresponding to the identification of the monitoring device. The event handling device is further adapted to transmit a signal including information corresponding to the identification of the monitoring device.
Patent MX-PA06013592-A (MX)
Title: Drip irrigation hose and method for making same.
Inventor: COHEN AMIR
IPC: A01G25/02
Filed: 2005-05-19
Abstract: A drip irrigation hose includes a plurality of emitter elements secured to a tube at longitudinally-spaced locations to define, with an inner surface of the tube, a plurality of labyrinths each having an inlet in communication with the interior of the tube, and an outlet in communication with a tube outlet for discharging water from the tube outlet at a slow rate. The labyrinths are defined by a continuous strip bonded to the inner surface of the tube, and including a relatively elastic material shaped to define at least the tips of a group of teeth for each of the emitter elements, and a rib extending transversely across a part of the flow path from the respective emitter inlet to the respective tube outlet. Each of the latter ribs is formed with a slit which automatically opens when the water pressure within the tube at the respective emitter unit reaches a predetermined minimum to permit flow from the respective emitter inlet to the respective tube outlet.
Patent MX-PA06014065-A (MX)
Title: Antibody drug conjugates and methods.
Inventor: POLAKIS PAUL
IPC: A61K47/48
Filed: 2005-05-31
Abstract: The present invention relates to antibody-drug conjugate compounds of Formula I: Ab-(L-D)p where one or more maytansinoid drug moieties (D) are covalently linked by L to an antibody (Ab) which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors. These compounds may be used in methods of diagnosis or treatment of cancer, and other diseases and disorders.
Patent MY-103555-A (MY)
Title: An explosive which includes an explosive emulsion.
Inventor: ARNO WERNER DOLZ
IPC: C06B47/14
Filed: 1986-11-27
Abstract: AN EXPLOSIVE WHICH INCLUDES AN EXPLOSIVE EMULSION COMPRISING A DISCONTINUOUS PHASE WHICH INCLUDES AN OXIDISING SALT AND A CONTINUOUS PHASE WHICH INCLUDES A FUEL AND WHICH IS IMMISCIBLE WITH THE DISCONTINUOUS PHASE; AMMONIUM NITRATE PRILLS; AND A WATER-RESISTING AGENT FOR INHIBITING DETERIORATION OF THE AMMONIUM NITRATE PRILLS IN THE PRESENCE OF WATER, WHICH AGENT HAS THE EFFECTIVE OF INHIBITING ACCESS OF WATER TO THE AMMONIUM NITRATE PRILLS. THE WATER-RESISTING AGENT MAY COMPRISE A MEMBER SELECTED FROM THE GROUP CONSISTING OF PETROLEUM SULPHONATES; GUAR GUMS IN CONJUNCTION WITH CROSS-LINKING AGENTS; ALKYL PHOSHATES; DERIVATIVES OF POLYISOBUTYLENE SUCCINIC ANHYDRIDE; AND MIXTURES OF TWO OR MORE THEREOF.